THYROCARE — Thyrocare Technologies Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Thyrocare Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	1,525	2,279	874	956	1,469
Depreciation
Non-Cash Items	-56.7	-124	259	239	180
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-611	-1,360	-227	11.7	-288
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,160	1,134	1,293	1,676	1,913
Capital Expenditures	-283	-378	-437	-616	-449
Purchase of Fixed Assets
Other Investing Cash Flow Items	-220	143	46.6	-297	-76.3
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-502	-236	-390	-913	-525
Financing Cash Flow Items	-7.1	-47.5	-13.3	-54.3	-30.7
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-616	-894	-862	-848	-1,304
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	42.4	4.3	41.4	-84.6	83.8